| |
| AAMA JP Morgan Healthcare Conference
|
| With Atul Butte (Distinguished Prof., University of California - San Francisco), Lloyd Minor (Prof. Otolaryngology, Stanford University School of Medicine), Carmen Chang (General Partner, NEA), Rebecca Stevenson (MD - Head of Life Sciences, Wells Fargo), Robert Warren (Prof. Surgery, UCSF), Jerry Iwata (Dir. - Life Sciences Group, Wells Fargo), Prof. W. John Kao (Head, BioMedical Cluster - Hong Kong Science & Technology Parks Corporation), Aashima Gupta (Dir. - Global Healthcare Solns, Google Cloud), Andrew Radin (Founder/CEO, twoXAR Inc), Aswin Gunasekar (Founder/CEO, Zeto), Adam Hanina (CEO, AiCure), John Sun (Managing Partner/Head of TMT Investment, New Horizon Capital), James Zhang (Chief Strategy Officer, Centrillion), Barbara Ralston (Strategic Development, Dignity Health International), Bob Li (Medical Oncologist & Physician Ambassador to China & Asia-Pacific, Bobst International Center), Edwin McCarthy (VP, Center for International Medicine). |
| Westin St Francis Hotel, 335 Powell St, San Francisco |
|
Jan 13 (Mon) , 2020 @ 08:00 AM
| |
$250 |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
Innovations in the technology sector & overall global development are coming together right now, bringing unprecedented growth & improvement to the healthcare & biotechnology sectors. Chief among the advances fueling this growth is artificial intelligence, or AI.
On January 13, 2020, AAMA is hosting its Global Healthcare Conference in San Francisco, held in conjunction with the industry's biggest healthcare symposium, J.P Morgan's Healthcare Conference. The AAMA Global Healthcare Conference AI: The Next Digital Frontier for Healthcare Innovation is bringing together recognized industry leaders, top global researchers & medical professionals, entrepreneurs, investors, & innovators from Silicon Valley & Asia to discuss the impacts of AI on biotechnology & healthcare.
Attendees of the AAMA Global Healthcare Conference will learn about highly relevant topics:
Data-driven technologies' impact on healthcare
Creative strategies for technology teams
Effects of new technology on patients' & providers' daily lives
Key points to build to attract investors looking to expand healthtech innovations
AAMA's Global Healthcare Conference will focus on healthcare & provide attendees the opportunity to learn more about AI's impact through keynote talks, panel discussions, showcases, & exhibitors. Expect to build network connections during lunch, coffee chats, & the closing reception.
Seating is limited at this exclusive conference, so register to reserve your spot today! The movers & shakers of the industry will be present on January 13, 2020 to discuss investment in healthcare & data-driven technology trends that are revolutionizing the industry. You do not want to miss out!
CONFIRMED SPEAKERS:
Atul Butte, MD, PhD
Priscilla Chan & Mark Zuckerberg
Distinguished Professor
Director, Bakar Computational Health Sciences Institute (bakarinstitute.ucsf.edu)
University of California, San Francisco
Chief Data Scientist
University of California Health (UC Health)
BIO
Lloyd B. Minor, MD
Carl & Elizabeth Naumann Professor for the Dean of the School of Medicine, Professor of Otolaryngology - Head & Neck Surgery, & by courtesy, of Neurobiology & Bioengineering
Stanford University School of Medicine
BIO
Carmen Chang
General Partner; Chairman & Head, Asia, Menlo Park & China
NEA
NEA focuses investment stages ranging from seed stage through growth stage across an array of industry sectors. With over $20 billion in assets under management, NEA was the world's largest venture capital firm in 2007.
BIO
Rebecca Stevenson
Managing Director, Head of Life Sciences
Wells Fargo
BIO
Robert S. Warren, MD
Professor of Surgery
UCSF
Co-Founder
MORE Health
MORE Health delivers access to the best physicians in the world through its cloud-based medical collaboration platform.
BIO
Jerry Iwata
Director, Life Sciences Group
Wells Fargo
BIO
Professor W. John Kao
Head, BioMedical Cluster
Hong Kong Science & Technology Parks Corporation
HKSTP is a public corporation set up by the Hong Kong Government in 2001 to foster the development of innovation & technology in Hong Kong.
BIO
Aashima Gupta
Director, Global Healthcare Solutions
Google Cloud
BIO
Andrew A. Radin
CEO & Co-Founder
twoXAR
twoXAR is a biopharmaceutical company that uses AI to identify & develop new medicines.
BIO
Aswin Gunasekar, MS, MBA
CEO & Founder
Zeto
Zeto provides convenient device platforms for better diagnosis & management of life-changing conditions.
BIO
Adam Hanina
CEO
AiCure
A venture & NIH-funded advanced data analytics company targeting the life science & healthcare industry
BIO
Iris S. Chan
Founder & CEO
Ameriway
Ameriway focuses on early-stage investments & cross-border trades between North America & Asia.
BIO
John Sun
Managing Partner/Head of TMT Investment
New Horizon Capital
New Horizon Capital is a private equity firm investing in growth & expansion stage companies in China.
BIO
James Zhang
Chief Strategy Officer
Centrillion Technologies
Centrillion Biosciences develops genomics & DNA analyses technology for personalized medicine, life sciences research, & bioinformatics.
BIO
Barbara Ralston
Strategic Development
Dignity Health International
President
Barbara Ralston & Associates
Former VP, International Medical Services
Stanford Medicine
BIO
Bob T. Li, MD, MPH
Medical Oncologist
Physician Ambassador to China & Asia-Pacific, Bobst International Center
Memorial Sloan Kettering Cancer Center (MSKCC)
BIO
Edwin McCarthy
Vice President, Center for International Medicine
City of Hope National Medical Center
BIO
Mark A. Davis, MD, MS
Vice President of Business Development & Medical Affairs
Brigham Health International
Executive Director of Business Development & Strategic Initiatives
Brigham & Women's Hospital
BIO
Chris Knackstedt
Founder
ValueIQ & Tellus Wellness
BIO
Pierre R. Theodore, MD
Vice President, Global External Innovation
Johnson & Johnson Innovation
BIO
Carrie Hurwitz Williams
Principal
McKesson Ventures
McKesson Ventures is a strategic venture firm backed by McKesson Corporation focusing on early & growth stage companies. McKesson Ventures targets companies that both catalyze & benefit from the key changes taking place in the U.S. health care landscape.
BIO
Michael Chan
Head of International Issuer Business
Hong Kong Exchanges & Clearing Limited (HKEx)
HKEX is a stock exchange based in Hong Kong. It is Asia's third-largest in terms of market capitalization behind the Tokyo Stock Exchange & Shanghai Stock Exchange, & the fourth single largest stock market in the world.
BIO
Mary Jo Potter
CEO & Managing Director
Healthcare Angels
General Partner
Keiretsu Capital
BIO
Xiaodong Jiang
Managing Partner
Long Hill Capital
Long Hill Capital is a leading venture capital firm investing in high-growth technology & healthcare companies in China.
BIO
Randy Williams
Founder & CEO
Keiretsu Forum
Keiretsu Forum is a global angel investor network with more than 2500 accredited investor members throughout 47 chapters on 3 continents.
BIO
George Ugras
Managing Partner
AV8 Ventures
AV8 Ventures is a $180mil early-stage Palo Alto & London based venture capital firm aiming to partner with visionary entrepreneurs who are changing the future in data-driven health, mobility & intelligent enterprise.
BIO
Brian A. Smith
Founder/CEO
RedCrow - Equity Crowdfunding
RedCrow connects financial & human capital to healthcare start-ups.
BIO
Ivanhoe Chang
Director
Hong Kong Economic & Trade Office
San Francisco
BIO
John Huber
National Sales Executive, Technology Banking Group
Wells Fargo
BIO
Lisa M. Lum
Executive Director
AAMA Silicon Valley
PRESENTER
Maryanne Morrow
CEO
9th Gear Technologies
A fintech blockchain company
BIO
PRESENTER
Anthony Diaz
Founder, CEO
Health Hero
Modern Health Engagement
BIO
PRESENTER
Iris Wedeking
Co-Founder & CEO
iDentical
BIO
PRESENTER
Cameron Caitlin
Chair of the Board & CEO
Otonexus
BIO
PRESENTER
Sameer Jafri
President/COO
Avive Solutions
BIO
***STAY TUNED FOR SPEAKER UPDATES!***
AGENDA AT A GLANCE
9:00am-9:30am: Registration
9:30am-10:00am: Opening Keynote, plus Q&A
Atul Butte, MD, PhD
Priscilla Chan & Mark Zuckerberg Distinguished Professor
Director, Bakar Computational Health Sciences Institute (bakarinstitute.ucsf.edu)
University of California, San Francisco
Chief Data Scientist, University of California Health (UC Health)
10:00am-10:50am: Panel Discussion: Every Healthcare Professionals Dream: AI in Data, Diagnosis & Patient Care
Moderator: Jerry Iwata, Director - Life Sciences Group, Wells Fargo
Aashima Gupta, Director, Global Healthcare Solutions, Google Cloud
Aswin Gunasekar, CEO, Zeto
Adam Hanina, CEO, AiCure
Professor W. John Kao, Head, BioMedical Cluster, Hong Kong Science & Technology Parks Corporation
Andrew Radin, CEO & Co-founder, twoXAR
10:50am-11:15am: AI Product Launch by MORE Health
11:15am-12:00pm: Keynote Fireside Chat
Moderator: John Sun, Managing Partner/Head of TMT Investment, New Horizon Capital
Iris S. Chan, Founder & CEO, Ameriway
James Zhang, Chief Strategy Officer, Centrillion Technologies
12:00pm-12:45pm: Lunch
12:45pm-1:05pm: Keynote Presentation
Lloyd B. Minor, MD., Carl & Elizabeth Naumann Professor for the Dean of the School of Medicine, Stanford University
1:05pm-1:50pm: Panel Discussion: Provider Perspectives on the Future of Healthcare
Moderator: Rebecca Stevenson, Managing Director, Head of Life Sciences, Wells Fargo
Robert S. Warren, MD, Co-founder, MORE Health
Bob T. Li, MD, MPH, Medical Oncologist, Memorial Sloan Kettering Cancer Center (MSKCC)
Edwin McCarthy, Vice President, Center for International Medicine, City of Hope National Medical Center
Barbara Ralston, Strategic Development of Dignity Health International, President of Barbara Ralston & Associates, former Vice President of International Medical Services, Stanford Medical
Mark A. Davis, MD, MS, Vice President of Business Development & Medical Affairs for Brigham Health International; Executive Director of Business Development & Strategic Initiatives for Brigham & Women's Hospital
1:50pm-2:10pm: Keynote Presentation
Chris Knackstedt, Founder, ValueIQ.; Founder, Tellus Wellness
2:10pm-2:55pm: Panel Discussion: Emerging Trends & Innovations in Biopharma
Pierre R. Theodore, MD, Vice President Global External Innovation, Johnson & Johnson Innovation
2:55pm-3:05pm: Coffee Break
3:05pm-3:25pm: Keynote Fireside Chat
Moderator: Jerry Iwata, Director - Life Sciences Group, Wells Fargo
Carrie Hurwitz Williams, Principal, McKesson Ventures
3:25pm-3:45pm: Keynote Presentation
Michael Chan, Head of International Issuer Business, Hong Kong Exchanges & Clearing Limited, HKEx
3:45pm-4:30pm: Panel Discussion: Venture Capital Investing in Silicon Valley & Asia: Healthcare Predictions for 2020 & Beyond
Moderator: Mary Jo Potter, Healthcare Angels
Carmen Chang, General Partner, Head, Asia, Menlo Park & China, NEA
Xiaodong Jiang, Managing Partner, Long Hill Capital
Brian A. Smith, Founder/CEO, RedCrow
George Ugras, Managing Director, AV8 Ventures
Randy Williams, CEO, Keiretsu Forum
4:30pm-5:25pm: Company Presentations by Top Innovators in Life Sciences & Healthcare Sectors
Health Hero - Modern Health Engagement.
Otonexus - Commercializing a ground-breaking ultrasound medical device to rapidly & accurately diagnose middle ear infections.
Avive - Developer of next generation Automated External Defibrillator (AED).
9th Gear - Same-Day FX & On-Demand Payment Liquidity.
iDentical - Developer of personalized dentail implants.
5:25pm-5:30pm: Remarks by Ivanhoe Chang, Director, Hong Kong Economic & Trade Office, San Francisco
5:30pm-7:00pm: Networking Reception sponsored by HKETO
7:00pm: Event Concludes
*Stay tuned for program updates!
THANK YOU TO OUR SPONSORS:
PLATINUM + VENUE SPONSOR:
|
|
|
|
|
|
|
|
